Literature DB >> 9211158

Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment.

E T Jensen1, B Giwercman, B Ojeniyi, J M Bangsborg, A Hansen, C Koch, N E Fiehn, N Høiby.   

Abstract

Cystic fibrosis (CF) patients often suffer from Pseudomonas aeruginosa lung infection yet the source of this organism is not known. In order to determine whether CF patients might be contaminated with P. aeruginosa from dental equipment, a total of 103 water samples from 25 dental sessions in Frederiksberg Municipal Oral Health Care Service were examined. Three samples (2.9%) were positive for P. aeruginosa. Three hundred and twenty-seven water samples from 82 dental sessions from various other Municipal Oral Health Services in Denmark, attended by CF patients, were also examined. Eighteen of 327 samples (5.5%) from nine sessions (11%) were positive for P. aeruginosa. In one case, genotypically identical (RFLP, pulsed-field gel electrophoresis) P. aeruginosa strains were found both in water from the dental equipment and in the CF patients sputum. This indicates a small risk for acquiring P. aeruginosa from dental sessions, which is however equal to the yearly 'natural background' incidence (1-2%) of acquisition of P. aeruginosa in our CF centre.

Entities:  

Mesh:

Year:  1997        PMID: 9211158     DOI: 10.1016/s0195-6701(97)90117-1

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  10 in total

Review 1.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.

Authors:  Sally Palser; Sherie Smith; Edward F Nash; Arnav Agarwal; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

3.  Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.

Authors:  Lars Jelsbak; Helle Krogh Johansen; Anne-Louise Frost; Regitze Thøgersen; Line E Thomsen; Oana Ciofu; Lei Yang; Janus A J Haagensen; Niels Høiby; Søren Molin
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

Review 4.  Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis.

Authors:  N Høiby
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

Review 5.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 6.  Dental treatment for people with cystic fibrosis.

Authors:  N Harrington; P J Barry; S M Barry
Journal:  Eur Arch Paediatr Dent       Date:  2016-05-04

7.  Healthcare-associated viral and bacterial infections in dentistry.

Authors:  A M G A Laheij; J O Kistler; G N Belibasakis; H Välimaa; J J de Soet
Journal:  J Oral Microbiol       Date:  2012-06-12       Impact factor: 5.474

8.  Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.

Authors:  Jochen G Mainz; Andrea Gerber; Michael Lorenz; Ruth Michl; Julia Hentschel; Anika Nader; James F Beck; Mathias W Pletz; Andreas H Mueller
Journal:  Case Rep Infect Dis       Date:  2015-03-18

Review 9.  Cross-transmission in the Dental Office: Does This Make You Ill?

Authors:  C M C Volgenant; J J de Soet
Journal:  Curr Oral Health Rep       Date:  2018-10-25

Review 10.  Demystifying the mist: Sources of microbial bioload in dental aerosols.

Authors:  Purnima S Kumar; Kumar Subramanian
Journal:  J Periodontol       Date:  2020-07-27       Impact factor: 4.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.